An Exercise Training Intervention for Depressive Symptoms in Youth With MS: A Randomized Controlled Feasibility Trial

Status unknownNot a drug-phase studyEarly (CIS/RIS)NCT06870968

What it found

Paper found, not read

A paper reports the results; we have not read it yet. See Papers below.

What was tested

Treatment tested

  • Exercise Training

Placebo

  • Mobility and Flexibility Training

What it measured

Main measures

  • Participant accrual rate

    From enrollment to the end of study

  • Fidelity of delivering the intervention

    From enrollment to the end of intervention at 20 weeks

  • Participant drop-out rate

    From enrollment to the end of study

  • Adverse event rate

    From enrollment to the end of study

    Safety
  • Completion rate of study measures

    From enrollment to the end of study

Who could take part

Early (CIS/RIS) · 11 to 25

Show the full criteria

Inclusion criteria

* Youth and young adults 11-25 years of age * MS diagnosis or clinically isolated syndrome per revised McDonald diagnostic criteria and International Pediatric MS Study Group Criteria * A score of 10 or above on the CES-DC scale.

Exclusion criteria

* Have non-specific white matter abnormalities and metabolic or infectious etiologies for white matter abnormalities * Do not speak and read English at a level needed to complete the questionnaires (4th grade level) * Have significant motor disability (EDSS ≥4) * Are at increased risk of cardiac or other complications of exercise testing, as determined by the pediatric neurologist or physician

As registered. Criteria can change, so ask the trial team or your neurologist.

About this trial

In the sponsor's words

This multi-center, randomized controlled feasibility trial will assess a 20-week home-based exercise intervention in youth with Multiple Sclerosis (MS). The goal is to determine the feasibility of conducting a larger, definitive trial on exercise training as a non-pharmacological approach to improve disease outcomes in this population. Participants will be randomized to either an Exercise Training group or a Mobility and Flexibility Training group. The investigators will evaluate differences between the two groups in physical activity levels, mediators of physical activity, and psychosocial outcomes. Assessments, including clinical exams, brain MRI, eye tracking, cognitive testing, blood draws, and questionnaires, will occur at baseline and after 20 weeks. Accelerometry will be done at baseline, 10 weeks, and 20 weeks to track physical activity. The primary objectives are to assess the feasibility of recruiting, retaining, and randomizing youth with MS and to evaluate adherence to the exercise intervention and coaching sessions. Exploratory objectives include examining changes in depressive symptoms, cognitive function, blood biomarkers (BDNF and irisin), brain volume, and fitness levels in response to the intervention. Approximately 40 participants will be enrolled from four sites in Canada and the United States. Primary outcomes include feasibility, acceptability, and fidelity measures. Exploratory outcomes include blood biomarkers, brain MRI, cognitive testing, and other neuropsychological measures.

Papers

Loading reviews and guidelines…

History

    1. Started

      Jun 2025

    2. Main results due

      Sept 2026

    3. Finished

      Sept 2026

    Assembled by software from public sources.